PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Ethiopia ranks 7th amongst the 22 high TB burden nations in the World and 3rd in Africa. Specifically, the prevalence and mortality of all forms of TB is estimated to be 579 and 92 per 100,000, respectively. The Federal Ministry of Health's (FMOH's) hospital data revealed that Tuberculosis is the leading cause of morbidity, the second cause of death and the third cause of Hospital admission. GOE has been combating TB since the 1960s via different approaches.
Despite these efforts, TB case detection is less than half of the World Health Organization
(WHO) global target, standing at 34% according to FMOH administration report. Poor
laboratory capacity, low index of suspicion by health workers at Primary Health Care
(PHC) units, drug supply issues, weak TB program management and limited community
access to services are among the reasons for the persistently low case detection
rate (CDR).
At present, USAID is implementing a TB program focusing on early detection/treatment, scale-up for MDR-TB response and several TB/HIV collaborative activities,that due to limited resources could only be done in a limited number of Health Zones. The HEAL TB Performance project represents USAID Ethiopia's most comprehensive TB effort to date.
The General Objective of the project is to significantly improve TB case detection and Treatment Success rate (CDR = 70% and TSR = 85%) in selected geographic areas in order to change regional TB indicators that will impact on national TB indicators.
Specific Objectives include ensuring working with and through RHB, HZs, and District staff to ensure:
100 % DOTS coverage in priority Zones by the end of the project in priority zones
EQA conducted regularly to all TB diagnostic centers in priority Zones by the end of the project in priority zones
No stock out of anti TB Drugs in all DOTS clinics in priority Zones by the end of the project in priority zones
Timeliness and completeness of recording and reporting (Quarterly cohort report) in priority zones
- HEWs to identify, refer and provide CB-DOTS treatment
Identification of retreatment cases/failures and establish system to transport specimens for culture and DST
- MDR TB data base of confirmed cases; placement on MDR-TB treatment
TB/HIV collaborative sites increased through PEPFAR partners
Infection control plans implemented in all DOTS centers in priority Zones by the end of the project
None
